EYE worth a watch today. in addition to the very strong revenue results which have yet to be factored into EYE share price US proposal for reimbursement changes to significantly benefit EYE came out last 24 hours.
sight sciences closest competitor (but with inferior device) up 20% overnight in US trading full details over on the EYE CMS reimbursement changes thread
Day trading pre-market open July 12, page-32
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)